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Bradykinin (BK) is produced and acts at the site of injury and inflammation. In the CNS, migration of microglia toward the lesion site
plays an important role pathologically. In the present study, we investigated the effect of BK onmicroglial migration. Increasedmotility
of cultured microglia was mimicked by B1 receptor agonists and markedly inhibited by a B1 antagonist, but not by a B2 receptor
antagonist. BK induced chemotaxis in microglia isolated from wild-type and B2-knock-out mice but not from B1-knock-out mice.
BK-induced motility was not blocked by pertussis toxin but was blocked by chelating intracellular Ca2 or by low extracellular Ca2,
implying that Ca2 influx is prerequisite. Blocking the reverse mode of Na/Ca2 exchanger (NCX) completely inhibited BK-induced
migration. The involvement of NCX was further confirmed by using NCX/ mice; B1-agonist-induced motility and chemotaxis was
decreased compared with that in NCX/mice. Activation of NCX seemed to be dependent on protein kinase C and phosphoinositide
3-kinase, and resultant activation of intermediate-conductance (IK-type) Ca2-dependent K currents (IK(Ca) ) was activated. Despite
these effects, BKdidnot activatemicroglia, as judged fromOX6staining.Using in vivo lesionmodels andpharmacological injection to the
brain, it was shown that microglial accumulation around the lesion was also dependent on B1 receptors and IK(Ca). These observations
support the view that BK functions as a chemoattractant by using the distinct signal pathways in the brain and, thus, attractsmicroglia to
the lesion site in vivo.
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Introduction
Activation of microglial cells, the resident macrophages of the
brain, occurs rapidly after brain injury (Kreutzberg, 1996; Kim
and Vellis, 2005). Activated microglia migrate rapidly to the af-
fected sites of the CNS. The nonapeptide, bradykinin (BK), is
produced in the brain during trauma and stroke, leading to an
increase in blood–brain barrier permeability and an accumula-
tion of leukocytes, and is therefore regarded as a mediator of
inflammation and vasodepression (Abbott, 2000; Lehmberg et
al., 2003). In the brain, BK has been assigned a neuroprotective
role (Yasuyoshi et al., 2000; Noda et al., 2007a), especially via BK
receptors in microglia (Noda et al., 2006, 2007a,b). BK receptors
are coupled tomultiple signal transduction pathways (Hall, 1992;
Noda et al., 2004). One is mobilization of intercellular Ca2 in-
duced by inositol 1,4,5-trisphosphate (IP3) and activation of
Ca2-dependent K (KCa) channels (Higashida and Brown,
1988), inducing activation of phospholipase A2 and stimulation
of arachidonic acid release (Welsh et al., 1988, Yanaga et al.,
1991). BK receptors also couple to Gi/o-proteins, leading to
mitogen-activated protein (MAP) kinase signal transduction
(Liebmann, 2001). In unstimulated cultured microglia, expres-
sion of both B1 and B2 receptors was low, but strong immunola-
beling of both B1 and B2 receptors was observed after the treat-
ment of the cells with BK (Noda et al., 2007a). It was also reported
that activation of BK receptors inmicroglia linked to activation of
KCa channels. It is nowwell established thatmicroglial cells can be
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neuroprotective or neurodestructive de-
pending on the pathologic context and the
type of stimulation (Pocock and Ketten-
mann, 2007). Our data indicate that BK
triggers responses in microglia, which ul-
timately results in a protection of neurons,
namely by inhibiting proinflammatory cy-
tokine release and thus attenuating an in-
flammatory response (Noda et al., 2007a).
Microglia are abundant in all regions of
the CNS. Under pathological conditions,
activated microglia can phagocytose dead
cells and clear cellular debris at the site of
injury (Raivich et al., 1999; Stoll and
Jander, 1999; Streit et al., 1999). There are
several candidate molecules that serve as
signals for pathologic events to microglia.
As recently shown byDavalos et al. (2005),
microglial processes rapidly respond to
ATP, and ATP has been reported to be a
chemoattractant for microglial cells
(Honda et al., 2001). A variety of other
signals stimulate microglial motility, such
as cannabinoids (Walter et al., 2003),
morphine (Takayama and Ueda., 2005),
or the chemokine CCL21 (Rappert et al.,
2002). Neuropeptides including BK are
another family of candidates (Palkovits,
1995).
In the present study, we investigated
the BK-induced increase in microglial mi-
gration and its underlying signaling cas-
cade. The results indicate that BK can at-
tract microglia to a lesion or inflammation sites, where BK is
known to be upregulated, because it is a chemoattractant and
increases microglial motility.
Materials andMethods
Cell culture. The study was approved by the Animal Research Committee
of KyushuUniversity andMax-Delbru¨ck Center forMolecularMedicine
and performed in accordance with the National Institutes of Health
Guide for the Care and Use of Laboratory Animals.
Rat microglial cells were isolated from mixed cultures of cerebrocor-
tical cells in postnatal day 3 Wistar rats (Kyudo, Kumamoto, Japan) as
described previously (Noda et al., 2003). In brief, for rat microglia, the
cerebral cortex was minced and treated twice with papain (90 U) and
DNase (2000 U) at 37°C for 15 min. Dissociated cells were seeded into
300 cm2 plastic flasks at a density of 107 per 300 cm2 in Eagle’s medium
(MEM) with 0.17%NaHCO3 and 10% fetal calf serum (FCS) and main-
tained at 37°C in 10% CO2/90% air. Medium was changed twice per
week. After 10–14 d, floating cells andweakly attached cells on themixed
primary cultured cell layer were obtained by gently shaking for 5–8 min.
Microglial cells were then isolated as strongly adhering cells after unat-
tached cells were removed. The purity of the microglial culture ranged
from 95 to 99%, which was evaluated by staining withGriffonia simplici-
folia isolectin B4, a marker for microglia.
Mouse microglial cells were isolated from total brain of newborn B1
receptor-knock-out (KO) (Pesquero et al., 2000), B2 receptor-knock-out
(Milia et al., 2001), and wild-type control mice (C57BL/6J) as described
previously (Prinz et al., 1999). In brief, cortical tissue was trypsinized for
2 min, dissociated with a fire-polished pipette, and washed twice. Mixed
glial cells were cultured for 9–12 d in DMEM supplemented with 10%
FCS, 2 mM L-glutamine, 100 U/ml penicillin, and 100 g/ml streptomy-
cin, with medium changes every third day. Microglial cells were then
separated from the underlying astrocytic layer by gentle shaking of the
flask for 1 h at 37°C in a shaker-incubator (100 rpm). The purity of
microglia was95%.Cells were used for experiments 1–5 d after plating.
Cell media and supplements were purchased from Seromed/Biochrom
(Berlin, Germany).
Motility experiment. Rat cultured microglia were seeded on glass-
bottom dishes (Matsunami, Osaka, Japan) at a density of 104 cells per
dish. Motility of microglia under the control of temperature (37°C) and
gas (10% CO2/90% air) was monitored with a time-lapse video micros-
copy system (Nikon Instec, Fukuoka, Japan). The video camera (Nikon
inverted microscope, TE-2000-E) was controlled by Luminavision soft-
ware (Mitani, Osaka, Japan). Images were acquired in 1min intervals for
1 h and stored on a computer and analyzed by Dipp-Motion 2D (Ditect,
Tokyo, Japan). Cell motility in response to BK and other chemicals was
assessed by adding stock solution to the dish, diluting 100 times to get the
final concentration. The diffusion of the drugs within the dish occurred
rapidly and had distributed before the first imagewas taken, as verified by
adding a dye.
Microchemotaxis assay. BK-induced chemotaxis was tested using a 48-
well microchemotaxis Boyden chamber (Neuroprobe, Bethesda, MD)
(Nolte et al., 1997). Upper and lower wells were separated by polycar-
bonate filter (8 m pore size; Poretics, Livermore, CA). Microglial cells
(2–4 104) in 50l of serum-freeMEMorDMEMmediumwere added
to the upper wells, and the lower wells containedmedium containing BK
with or without other drugs. Culture medium (MEM or DMEM) was
used as a control. The chamber was incubated at 37°C and 5% CO2 for
180 min. Cells remaining on the upper surface of the membrane were
removed by wiping, andmigrated cells were subjected to Diff-Quik stain
(Sysmex, Kobe, Japan). The rate of microglial migration was calculated
by counting cells in four random fields of each well using a 40 bright-
field objective. The number of cells was50–80 cells per field in control
condition, and the number of fields in each conditionwas 92–152 (23–38
wells). The number of cells in each field was normalized to the average in
control condition (100%).
Figure1. Motility of BK-stimulatedmicroglial cells.A,Microglial cellswere stimulatedwith 300nMBKandwere recordedusing
time-laps imaging system every 5 min. The images show at 0, 30, and 60 min after application of BK. B, Effects of different
concentration of BK onmicroglial motility. Total distance (inmicrometers) ofmicroglial cells for 1 hwas significantly increased by
BK at 100, 300, and 1000 nM. **p 0.01; ***p 0.001. Effects of bradykinin receptor antagonist and agonist. C, B1 receptor
antagonist, Des-Arg 9-[Leu 8]-bradykinin (1M), inhibited BK-induced microglial motility. ***p 0.001, significantly different
from control. #p 0.05, ###p 0.001, significantly different from B1 antagonist.D, B2 receptor antagonist, Hoe140 (1M), did
not inhibit BK-induced microglial motility. ***p 0.001. E, Total distance (in micrometers) of microglial migration for 1 h was
increased by B1 agonist, Des-Arg
10-kallidin (300 nM). F, Another B1 agonist, Des-Arg
9-bradykinin (300 nM), also increasedmicro-
glial motility. *p 0.05; ***p 0.001.
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Immunocytochemical analysis. Rat primary cultured microglia were
fixed with 4% paraformaldehyde, treated with a primary antibody
against activated microglia, OX6 (1:250) (PharMingen, San Diego, CA)
together with goat serum (10% in volume) for overnight at room tem-
perature, washed four times, and then incubated with the Alexa Fluor
594-conjugated goat anti-mouse (1:200) antibody (Invitrogen, Carlsbad,
CA) together with goat serum (10% in volume) at room temperature for
6 h. Series of images were examined with a confocal laser-scanning mi-
croscope (LSM510;Carl Zeiss,Oberkochen,Germany). The fluorescence
intensity was measured by Photoshop (Adobe Systems, San Jose, CA).
Lesion model mice.Male C57BL/6 mice (8–12 weeks old) and BK1 and
BK2 receptor-knock-out mice (8–12 weeks) were anesthetized with pen-
tobarbital (12.5 mg/kg) and placed in a stereotactic apparatus. A 2-l
Hamilton syringe with a 26 or 23 gauge needle was inserted into the right
cortex through a small hole drilled through the skull. For cortex lesion,
themicrosyringe was inserted into brains of knock-out or wild-typemice
at the following coordinates; anterior, 1 mm; lateral, 2.2 mm; and dor-
soventral, 4 mm. For injection of charybdotoxin (CTX) (0.1 M) or PBS
(both in 1 l volume) in C6BL/6J mice (Kyudo, Saga, Japan), the needle
was lifted for 1 mm. n 3–4 animals were used per experimental group.
Eighteen hours after making lesion by insertion of microsyringe or mi-
croinjection of CTX or PBS, each mouse was anesthetized with pento-
barbital (12.5 mg/kg) and transcardially perfused with 20 ml each of 10
U/ml heparin and 0.5% procaine in PBS and 4% paraformaldehyde.
Then the brainwas removed, postfixed for 3 h, and cryoprotected for 24 h
in PBS containing 20% sucrose and 0.05% sodium azide.
Immunofluorescent labeling withmicroglia.The brainwas sliced into 20
m in thickness using a cryostat, and the sections were placed on a slide
glass precoated with silane and stored at80°C until the time to use. The
coronal sections were cut from part of the cortex. The sections were
permeabilized with 0.3%Triton X-100 (Sigma, St. Louis,MO) in PBS for
15 min and blocked in PBS containing 1% BSA and 5% normal donkey
serum (Jackson ImmunoResearch, West Grove, PA) for 60 min at room
temperature. The brain sections were incubated overnight at 4°C with
primary antibody, rabbit anti-Iba1 antibody (1:500; Wako, Richmond,
VA), and incubated for 5 h with Alexa Fluor 488 goat anti-rabbit IgG
(1:250; Invitrogen) at room temperature. Every treatment was followed
bywashing three times for 5minwith PBS. Sections weremounted in the
Permafluor aqueous mounting medium (Thermo Fisher Scientific,
Waltham,MA) and were analyzed with a confocal laser-scanningmicro-
scope (LSM510 Meta; Carl Zeiss).
Quantification of microglia number around the lesion site.Microglia in
the sections containing lesionwere immunohistochemically stainedwith
anti-Iba-1 as mentioned above. The number of microglia in 60–80 areas
of 100  100 m around the lesion site in five slices per brain was
counted, and the averaged number per 104 m2 for each brain was
obtained.
Statistical analysis. The results are expressed as the mean SEM. The
data were compared with Student’s t test or one-way ANOVA followed
by the Scheffe´ or Dunnett’s test, using software package Statview 5.0J.
Values of p 0.05 were considered statistically significant.
Drugs and reagents. BK was from Peptide Institute (Osaka, Japan) or
Sigma. ATP, Griffonia simplicifolia isolectin B4 3	, and 4	-
dichlorobenzamil hydrochloride were from Sigma. Charybdotoxin, ibe-
riotoxin, apamin, staurosporine, wortmannin, chelerythrine chloride,
and PD98059 (2	-amino-3	-methoxyflavone) were from Sigma. Des-
Arg9-[Leu8]-bradykinin, Hoe140, Des-Arg9-bradykinin, and Des-
Arg10-kallidin were from Peptide Institute (Osaka, Japan). Pertussis
toxin (PTX) was from List Biological Laboratories (Campbell, CA). KB-
R7943 (2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea, methane
sulfonate) was from EMD Biosciences (San Diego, CA). Gadolinium
oxide was from Ishizu Seiyaku (Osaka, Japan). SN-6 was provided by
Senju Pharmaceutical (Kobe, Japan).
Results
Bradykinin-inducedmotility of microglia is mediated by B1
receptors but not by B2 receptors
To examine the motility of microglia, individual cells were mon-
itored by time-lapse video microscopy for 1 h. Figure 1A shows
images of cultured microglial cells at 0, 30, and 60 min after
addition of 300 nM BK. A significant increase in microglial mo-
tility was observed already after 15 min (data not shown). The
increase in microglial motility could be monitored for up to 18 h
(data not shown). The average distance of microglial migration
determined within 1 h increased significantly in the presence of
BK. However, there was no significant difference between 100,
300, and 1000 nM BK (Fig. 1B).
To determine the type of BK receptor mediating BK-induced
microglialmotility, we tested the effect of selective antagonists for
Figure 2. Microglial chemotaxis in three genotypes of bradykinin receptors. A, BK-induced
microglial chemotaxis inwild-type (Wild)mice.B, In B1 receptor-knock-outmice (B1-KO), 100
and300nMBKdidnot induce chemotaxis.C, InB2 receptor knock-outmice (B2-KO), BKat either
concentration induced microglial chemotaxis. **p 0.005; ***p 0.001.
Figure 3. Effects of PTX and inhibitors of protein kinases. A, Total distance (in micrometers)
ofmicroglial migration for 1 h ofmicroglial cells was increased by ATP. Pretreatment of PTX (50
ng/ml) for 12 h (with additional 50 ng/ml PTX before application of ATP) almost completely
blocked the effect of ATP. ***p 0.001, significantly different from control. ###p 0.001,
significantly different from ATPPTX. B, PTX did not affect BK (300 nM)-induced microglial
motility (n 20). ***p 0.001. C, BK-induced microglial motility was inhibited by pretreat-
ment of PKC inhibitor, chelerythrine (Chel; 10 M), for 24 h. A part of BK-induced microglial
motility was inhibited by pretreatment of PI3 kinase inhibitor, wortmannin (Wort; 1M), for
24h. ***p0.001; ###p0.001.D, BK-inducedmicroglialmotilitywas inhibitedbypretreat-
ment of PKC inhibitor, staurosporine (Staur; 10 nM) for 24 h. However, BK-induced microglial
motility was not affected by pretreatment of MAP/ERK inhibitor, PD98059 (PD; 10M), 24 h.
***p 0.001; ###p 0.001.
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B1 and B2 receptor on BK-induced motil-
ity. Figure 1, C and D, shows the effects of
Des-Arg9-[Leu8]-bradykinin, a B1 recep-
tor antagonist, and Hoe140, a B2 receptor
antagonist, on the BK-induced increase in
microglial motility. BK-induced micro-
glial motility was decreased by 70% by
the B1 antagonist (Fig. 1C), but was not
affected by the B2 antagonist (Fig. 1D).
This represents that BK-induced micro-
glial motility was caused by the activation
of B1 receptors.
Consistent with the previous results,
two B1 agonists, Des-Arg
9-bradykinin and
Des-Arg10-kallidin, mimicked the re-
sponse of BK (Fig. 1E,F). These results
indicate that B1 receptors, but not B2 re-
ceptors, are responsible for BK-induced
increase in microglial motility.
BK-inducedmicroglial chemotaxis in
B2- but not B1-knock-out mice
To confirm the pharmacological data, we
used B1 and B2 receptor-KO mice and
studied the BK-induced chemotaxis ofmi-
croglia using amicrochemotaxis (Boyden)
chamber. In wild-type mice, BK at concen-
trations of 100 and 300 nM significantly in-
creased microglial migration. The relative
increases inmigrationby100and300nMBK
were 134  1.89% (n  152) and 124 
1.99% (n 148), respectively (Fig. 2A).
In B1-KOmice, 100 and 300 nM BK did
not increase microglial migration (Fig.
2B). In contrast, in B2-KO mice, micro-
glial migration induced by BK was similar
to that inwild-typemice. BK increased cell
migration to 118  4.12% (n  96) and
140  3.26% (n  92) with 100 and 300
nM BK, respectively (Fig. 2C).
Gi/o-protein was not involved in BK-
inducedmicroglial motility
The ATP-increased microglial migration
via P2Y12 receptor is coupled to a PTX-
sensitive Gi/o-protein (Honda et al., 2001).
BK receptors have also been reported to
couple to Gi/o-protein, leading toMAP ki-
nase signaling (Liebmann, 2001). There-
fore, we investigated whether Gi/o-protein
was involved in BK-induced increase in
microglial motility. As a positive control,
the ATP-induced increase in microglial
motility could be completely inhibited by
pretreatment with PTX for 12 h (Fig. 3A),
as reported previously (Honda et al.,
2001). In contrast, pretreatment with PTX
for 12 h did not affect the BK-induced in-
crease in microglial motility (Fig. 3B).
These results suggest that PTX-sensitive
G-proteins (Gi/o) are not involved in the
BK-induced increase in microglial
motility.
Figure 4. Extracellular Ca 2 and activation of intermediate-conductance IK(Ca) was important for BK-induced microglial mo-
tility. A, Microglial motility in the presence of BKwas significantly inhibited by pretreatment with BAPTA-AM (10M) for 20min.
***p 0.001; ###p 0.001.B, In the absence of extracellular Ca 2 ([Ca 2]o 0), total distance (inmicrometers) ofmicroglial
migrationwasnot affectedbyBK (300nM) (n19), Des-Arg 9-bradykinin (300nM) (n18), or Des-Arg 10-kallidin (300nM) (n
18). C, BK-induced increase in microglial motility was inhibited by CTX (0.1M). D, ATP (50M)-inducedmicroglial motility was
not affected by CTX (0.1 M). E, Iberiotoxin (IBX) and apamin (APA), LK-type (large-conductance) and SK-type (small-
conductance) IK(Ca) blockers, respectively, had no effect on BK-induced microglial motility. ***p 0.001;
###p 0.001.
Figure 5. Activation of reverse mode of Na/Ca 2 exchanger was important for bradykinin-induced microglial motility. A,
BK-induced microglial motility was inhibited by KB-R7943, a specific inhibitor of reverse-mode NCX. BK-induced microglial mo-
tility was not affected by gadolinium (Gd 3, 100M), an inhibitor of capacitative Ca 2 channels. ***p 0.001; ###p 0.001.
B, BK-induced microglial motility was inhibited by KB-R7943 dose dependently. ***p 0.001; ###p 0.001. C, B1 agonist
(Des-Arg 9-BK)-inducedmicroglialmotilitywas inhibited by SN-6 (5 and 10M), amore specific inhibitor of reverse-modeNCX.D,
B1 agonist (Des-Arg
9-BK)-inducedmicroglialmotility inwild-type (NCX/)mice (openbar) andNCXknock-out (NCX/)mice
(filled bar). In NCX/mice, 300 nM Des-Arg9-BK inducedmicroglial motility was 1.7-fold increased, whereas in NCX/mice,
Des-Arg 9-BK-inducedmicroglialmotilitywasonly 1.3-fold increased. ***p0.001; ###p0.001. n.s., No significant difference.
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PKC and PI3K but not MAP/ERK
signaling were involved in BK-induced
microglial motility
BK receptors were reported to couple to
Gq/11 protein and its downstream contains
several protein kinases such as protein ki-
nase C (PKC) (Higashida and Brown,
1988) and phosphoinositide 3-kinase
(PI3K). The PKC inhibitors, staurospor-
ine and chelerythrine, inhibited the in-
crease in BK-induced microglial motility
(Fig. 3C,D). BK-inducedmicroglial motil-
ity was partially inhibited by wortmannin,
a PI3K inhibitor (Fig. 3C), suggesting that
PI3K was also involved in the increase in
microglial migration induced by BK.
On the other hand, BK-inducedmicro-
glialmotility was not affected by PD98059,
a MAP kinase/extracellular signal-
regulated kinase (ERK) inhibitor (Fig.
3D). These results suggested that PKC-
induced phosphorylation and PI3K were
important for BK-induced microglial
motility.
Intracellular and extracellular Ca2
were important for BK-induced
microglial migration
Microglial motility in the presence of BK
was significantly inhibited when the cells
were preincubated with 10 M BAPTA-
AM, an intracellular Ca2 chelator (Fig.
4A). In nominally free extracellular Ca2
solution, the basal level of microglial mo-
tility was reduced and was no longer af-
fected by either BK or the B1 agonists Des-
Arg9-bradykinin (300 nM) and Des-
Arg10-kallidin (300 nM) (Fig. 4B). These
results indicate that Ca2 influx and the
subsequent increase in intracellular Ca2
are necessary for BK-induced microglial
migration.
Activation of intermediate-conductance
Ca2-activated K channels was
involved in BK-inducedmicroglial
motility
As an effector for downstream signaling by
increased intracellular Ca2, activation of
Ca2-dependent K channels was tested
using specific channel blockers. In the
presence of 0.1 M CTX, a blocker of
Ca2-dependent K currents (IK(Ca)), BK
did not increase microglial motility (Fig.
4C). This result suggests that activation of
IK(Ca) is required for BK-induced increase
in microglial motility. In contrast, ATP-
induced microglial motility was not af-
fected by CTX (Fig. 4D).
Because CTX is a blocker for both
intermediate-conductance (IK-type) and
large-conductance (LK-type) IK(Ca), we
used a specific blocker for the LK-type,
Figure 6. B1 agonist-induced microglial chemotaxis, determined by Boyden chamber, was dependent on NCX and IK(Ca)
activity. A, Des-Arg 9-bradykinin (300 nM)-induced microglial chemotaxis was inhibited by DCB (10 and 20 M), an
inhibitor of NCX. ***p 0.001; ###p 0.001. B, CTX (0.1 M) inhibited microglial chemotaxis induced by B1 agonists,
Des-Arg 9-bradykinin (300 nM) and Des-Arg 10-kallidin (300 nM). ***p 0.001; ###p 0.001. C, Des-Arg 9-bradykinin
(300 nM)-induced microglial chemotaxis was inhibited by SN-6 (5 and 10M). ***p 0.001; ###p 0.001. D, Des-Arg 9-
bradykinin (300 nM) induced microglial chemotaxis in wild-type (NCX/) mice (open bar), but not in NCX knock-out
(NCX/) mice or when Des-Arg 9-BK was added to both upper and lower wells to eliminate the concentration gradient
(No gradient). ###p 0.001. n.s., No significant difference.
Figure 7. Possible signal transduction caused by activation of B1 receptor. Bradykinin is produced at site of tissue injury.
Bradykinin is rapidly degraded by peptidases known as kininase I, which cleave off C-terminal arginine (Arg 9) to generate
Des-Arg 9-bradykinin. Activation of the B1 receptor and coupling to Gq/11 results in the activation of PLC and PKC. PKC can
phosphorylateNCXand increaseNCXactivity and subsequentmobilizationof intracellular Ca 2. Increase in intercellular Ca 2 can
activate Ca 2-dependent K channels. Resulting hyperpolarization may induce microglial motility and chemotaxis. Activation
of the B1 agonist also couples the B1 receptor to MAPK signaling, which involves activation of Ras and consecutive stimulation of
PI3K. PI3K was involved in a part of microglial motility.
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iberiotoxin, and, in addition, a specific
blocker for small-conductance (SK-type)
IK(Ca), apamin. Figure 4E shows that BK-
induced microglial motility was not af-
fected by iberiotoxin nor apamin. These
results suggest that the IK-type IK(Ca) is
probably responsible for BK-induced mi-
croglial migration.
Reverse-mode (Ca2 entry mode) of
NCX as a mechanism of Ca2 influx
To elucidate the mechanism of extracellu-
lar Ca2 influx, we tested the influence of
Na–Ca2 exchanger (NCX) activity on
BK-induced migration, because NCX is
involved in the regulation of intracellular
Ca2 concentration ([Ca2]i), either with
forward-mode (Ca2 extrusion) or re-
verse mode (Ca2 influx). In the CNS,
three isoforms (NCX1–3) and several
splicing variants are expressed in neurons,
oligodendrocytes, astrocytes (Quednau et
al., 1997; He et al., 1998), and microglia
(Nagano et al., 2004). In pathological con-
ditions such as interferon- (IFN-) or ni-
tric oxide exposure, the activity and ex-
pression of NCX increased in microglia,
causing Na-dependent Ca2 uptake
(Matsuda et al., 2006). These results imply
that NCX-induced Ca2 influx plays a key
role in microglial function.
To examine whether Ca2 influx via NCX is involved in BK-
inducedmicroglialmotility, we used two benzyloxyphenyl inhib-
itors, KB-R7943 and SN-6, specific inhibitors of NCX in reverse
mode (Iwamoto et al., 1996a, 2004). BK-induced microglial mo-
tility was completely inhibited by 30 and 50 M KB-R7943 (Fig.
5B). On the other hand, BK-induced microglial motility was not
affected by gadolinium (Gd3), an inhibitor of capacitative cal-
cium entry channels (Fig. 5A). Furthermore, we used SN-6, a
specific NCX inhibitor, more than KB-R7943 (Iwamoto, 2004).
Des-Arg9-BK (B1 agonist)-induced microglial motility com-
pletely inhibited by 5 and 10 M SN-6 (Fig. 5C). Next, we used
heterozygous NCX knock-out mice (NCX/), because the ho-
mozygous (NCX/) deletion is lethal (Wakimoto et al., 2000).
Using NCX/ mice, 300 nM Des-Arg9-BK-induced microglial
motilitywas significantly attenuated comparedwith the one from
wild-type (NCX/)mice. On the other hand, ATP-inducedmi-
croglial motility showed no difference between wild-type and
NCX/ mice (Fig. 5D). These results suggest that Ca2 influx
via NCX is prerequisite for BK- and B1 agonist-induced micro-
glial motility.
We also tested the involvement of NCX and activation of
IK(Ca) in BK- and B1 agonist-induced chemotaxis using the Boy-
den chamber. Another NCX inhibitor, 3	,4	-dichloro-
benzamil (DCB) (Plasman et al., 1991, Krasznai et al., 2006),
inhibited BK-induced chemotaxis at concentrations of 10 and 20
M, to the control level (Fig. 6A). DCB alone did not affect the
microglial chemotaxis.
The importance of activation of IK(Ca) was also confirmed in
BK-induced chemotaxis. B1 agonists, Des-Arg
9-bradykinin (300
nM) and 300 nMDes-Arg10-kallidin, increased chemotaxis in cul-
tured rat microglia by 177  8.41% (n  16) and 152  6.76%
(n 16), respectively. These increases in chemotaxis were com-
pletely blocked by 0.1 M CTX (Fig. 6B).
Furthermore, we usedNCX/mice and SN-6 in chemotaxis.
Des-Arg9-BK-inducedmicroglial chemotaxis was completely in-
hibited by 5 and 10M SN-6 (Fig. 6C). In wild-typemice, micro-
glial chemotaxis induced by Des-Arg9-BK was similar to that in
cultured rat microglia. In contrast, in NCX/ mice, 300 nM
Des-Arg9-BK did not induce microglial chemotaxis (Fig. 6D).
Des-Arg9-BK-induced microglial chemotaxis was almost the
same as the control level when Des-Arg9-BK was added to both
sides of the membrane (lower and upper well) to eliminate the
concentration gradient (no gradient).
Signal cascade from B1 receptor in microglia
The above in vitro experiments using cultured microglia suggest
the signaling cascade for BK-induced microglial migration
shown in Figure 7. Thus, BK (B2 agonist) is enzymatically metab-
olized to B1 agonist by kininogen, which in turn, working on B1
receptors, coupled to Gq/11 proteins, activates PKC and PI3K,
phosphorylates and activates NCX, inducing influx of extracellu-
lar Ca2, activates IK(Ca), and then induces microglial migration
by hyperpolarization or some other mechanisms.
Bradykinin did not induce OX6 expression in microglia
Activated microglia are known to express the class 2 major histo-
compatibility complex (MHC-2). MHC-2 expression as deter-
mined by OX6 immunoreactivity was used as indicator for mi-
croglial activation (Majed et al., 2006). As a positive control,
microglial cells were treated with IFN- (50 U/ml) and ATP (50
M) (Fig. 8A). The fluorescence intensity of OX6 was signifi-
cantly increased by IFN- and ATP, but not by BK (Fig. 8B) This
indicates that BK did not induce microglial activation. We also
tested the involvement of Rho and cyclic adenosine-
Figure 8. Bradykinin did not stimulate MHCII expression. A, The cells were treated with 50 U/ml IFN-, 50M ATP, or 300 nM
BK for 24 h. Differential interference contrast (DIC) image and immunofluorescence stainedwith anti-OX6 antibody (labeledwith
Alexa Fluor 568; red) are shown. Scale, 100m. B, The relative fluorescence intensity of OX6 immunoreactivity. The intensity of
fluorescenceafter applicationof IFN-, ATP, orBK stimulationwasnormalized to theone inuntreated (control)microglia. ***p
0.001; ##p 0.01; ###p 0.001.
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ribose(cADPR), but they were not involved (supplemental Fig. 1,
available at www.jneurosci.org as supplemental material).
Bradykinin acts as an inducer of microglial migration in vivo
It is important to knowwhether the phenomena described above
occur in vivo, i.e., whether BK produced at the site of injury
attracts microglia for either neuroprotection or cleaning up de-
bris. Therefore, we comparedmicroglial density 18 h after a focal
stab wound injury in normal and B1- and B2-deficient adult mice
(Fig. 9A–C). Because BK is not the onlymediator produced at the
lesion site, BK-induced microglial accumulation would be only
partial. Nonetheless, microglial accumulation in B1-knock-out
mice was significantly decreased compared with that in wild-type
mice. In wild-type mice, the average microglial density at the
lesion site was 14.43  0.69 (n  3) in the 104 m2 inspected
areas, whereas in the same region at the contralateral side, it was
2.73 0.17. In B1-knock-out mice, microglial accumulation was
significantly decreased (11.03  0.35, n  4) compared with
wild-type mice (Fig. 9G). Microglial density at the contralateral
side was 2.19 0.21 in the B1-knock-out mice. In B2-knock-out
mice, microglial density was 12.83  0.40 at the lesion site and
2.29 0.28 at the contralateral side (n 3).
We also examined whether blocking the downstream compo-
nents of BK-induced signal transduction also inhibited the mi-
croglial migration. Injection of CTX (0.1 M, 1 l) significantly
inhibited microglial migration to the lesion site compared with
that in control (injection of PBS) (Fig. 9D,E). The average num-
bers of microglia around the lesion in PBS and CTX-injected
brain were 14.62 0.63 (n 3) and 10.62 0.60 (n 3) per 104
m2, respectively (Fig. 9G), indicating
that CTX impairs the accumulation at the
lesion site. At the contralateral side (Fig.
9F), microglial density was 2.13 0.19 in
CTX-injected and 2.23  0.16 in PBS-
injected animals.
Discussion
Bradykinin inducedmicroglial
migration by stimulating B1 receptors
In the brain, BK receptors are expressed in
allmajor cell types, neurons (Delmas et al.,
2002), astrocytes, oligodendrocytes
(Ritchie et al., 1987; Gimpl et al., 1992;
Hosli et al., 1992; Lin and Chuang, 1992;
Stephens et al., 1993), and microglial cells
(Noda et al., 2003). Two subtypes of BK
receptors have been distinguished, termed
B1 and B2 receptors. B1 receptor mRNA is
expressed at very low levels in microglia
under normal conditions, but is upregu-
lated after application of BK (Noda et al.,
2003, 2007a). In the present study, we pro-
vide evidence that the BK-induced migra-
tion, both motility and chemotaxis, is me-
diated by B1, but not by B2 receptors,
because the response can be mimicked
with B1-specific agonists and blocked by
B1-specific antagonists. This was sup-
ported by results obtained using B1- and
B2-deficient mouse lines. Combined with
a chemotactic response, a general increase
inmotility will result in a faster accumula-
tion of the cells at the lesion site.
The signal cascade of B1 receptor activation
We have obtained evidence that BK would be produced after
lesion in vivo and identified several steps in the intracellular sig-
naling cascade followed by B1 receptor activation in vitro, as
shown in Figure 7. The first step is the production of BK or
kallidin at the lesion site. These are rapidly degraded by pepti-
dases known as kininases, because the half-life of BK is reported
to be 30 s in plasma (Kariya et al., 1982). The degraded BK
becomes B1 agonist and activates the B1 receptor linked to a PTX-
independent G-protein, presumably Gq/11. Activation of mem-
bers of theGq/11 family is involved in phosphoinositide (PI) turn-
over and the mobilization of intracellular Ca2 (Noda et al.,
2004). Although BK triggered a transient increase in intracellular
Ca2 (Noda et al., 2007b) and a transient activation of Ca2-
dependent K currents (IK(Ca)) in microglia (Noda et al., 2003),
some observations indicate that the long-term effect of BK on
migration is caused by a different signaling mechanism. This is
based on the observations that (1) the population of cells showing
the transient (IP3-induced) increase in intracellular Ca
2 or
IK(Ca) were 20%, whereas 80% of microglial cells showed
BK-induced migration; and (2) BK-induced migration depends
on extracellular Ca2 levels (Fig. 4).
Our data indicate that reverse-mode operation of NCX pro-
vides the influx of Ca2. This Ca2 influx would in turn induce a
more persistent activation of IK(Ca). Persistent IK(Ca) activation
appears to be an important step in stimulating migration, be-
cause blocking IK(Ca) completely inhibitedBK-inducedmigration
(Figs. 4, 6B). A similar observation was reported for lysophos-
Figure 9. Bradykinin acts as an inducer of microglial migration in vivo. A–C, B1 receptors play an important role in migration
and accumulation of microglia. Microglial cells around lesion were stained immunohistochemically with anti-Iba-1 in wild-type
(A), B1-knock-out (B), and B2-knock-out mice (C). D, E, Ca
2-dependent K channels play an important role in migration and
accumulation of microglia. Injection of CTX inhibited the number of microglia around lesion (E) compared with that in control
(PBS-injected; D). F, Microglial distribution at contralateral cortex in control brain (D). G, The number of microglia around lesion
was decreased in B1-knock-out mice and CTX-injected brain compared with the one in wild-type and B2-knock-out mice and
control (PBS-injected) brain, respectively. Numbers of cells are represented asmean SEM. *p 0.05; ***p 0.001. Scale bar,
100m.
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phatidic acid-induced microglial migration: it also depended on
the activity of intermediate-conductance IK(Ca) (Schilling et al.,
2002; Eder, 2005). One possibility is that the hyperpolarization
induced by IK(Ca) increases the driving force (the electrochemical
gradient) for Ca2 influx and thus enhances the intracellular
Ca2 signal required to stimulate cell migration.
We found that activation of the kinases PKC and PI3K are
important in mediating the effects of bradykinin. This may be
attributed to phosphorylation of NCX, because PKC can phos-
phorylate NCX, and most, but not all, studies have reported
PKC-mediated increase in NCX activity (Vigne et al., 1988;
Iwamoto et al., 1996b). The involvement of PKC and tyrosine
kinase in controlling NCX activity in microglia has previously
been reported by Matsuda et al. (2006). PI3K is also involved in
reverse mode of NCX activity, as observed in neonatal cardiomy-
ocytes (McDowell et al., 2004). Because activation of PKC and
PI3K could be also a downstream consequence of PI turnover,
our results suggest that B1-induced activation of PKC, and pre-
sumably also PI3K, was linked to activation of NCX inmicroglia.
Distinct mechanisms of microglial migration induced by BK
and ATP
Our data showed that microglial migration induced by BK and
that induced by ATP were caused by different mechanisms. BK-
and lysophosphatidic acid-induced migration was controlled by
a Gi/o-protein-independent pathway, leading to an activation of
IK(Ca), whereas ATP-induced migration was via a Gi/o-protein-
dependent but not IK(Ca)-dependent pathway. Another difference
between ATP and BK was that BK did not significantly induce
membrane ruffling in microglia (data not shown), as observed
withATP (Honda et al., 2001). Furthermore, ATP and IFN-, but
not BK, increased the expression of OX6 (Fig. 8), a parameter of
microglial activation. These differences indicate that ATP andBK
control distinct microglial functions in pathological conditions
such as lesion and inflammation.
New signaling by bradykinin in microglia
BK is widely accepted as a signaling substance that mediates pain
and inflammation, whereas the role of BK in the normal, healthy
CNS still remains unknown. Recently, a neuroprotective role for
BK after a neurotoxic insult has been reported (Yasuyoshi et al.,
2000; Noda et al., 2007a). Becausemicroglial cells are the primary
immune effector cells in the brain and highly dynamic surveil-
lants of brain parenchyma (Nimmerjahn et al., 2005), BK would
be an important mediator to attract microglial cells to the site of
lesion. Interestingly, the link between bradykinin and microglial
migration is mediated by B1 but not by B2 receptors. B1 receptors
are upregulated in microglia in response to activation [e.g. by
lipopolysaccharide (LPS)]. A similar upregulation of B1 receptor
subtype was observed in other cells treated with LPS, cytokine,
heat stress, or endotoxin (Galizzi et al., 1994; Campos et al., 1996;
Nicolau et al., 1996; Lagneux and Ribuot, 1997; Busser et al.,
1998; Schremmer-Danninger et al., 1998; Wille et al., 2001). An-
other interesting observation was the involvement of NCX oper-
ating in reverse mode leading to Ca2 influx. Although the phys-
iological function of NCX is assumed to be Ca2 extrusion,
Matsuda et al. (2006) provide evidence thatCa2uptake viaNCX
operating in reversemodemay play a role formicroglial function
under pathological conditions. The signaling cascade of BK and
its coupling to NCX might be quite distinct in microglia com-
pared with other cell types. Our results indicate that BK is an
important signaling substance that affects microglial functions
via activation of B1 receptors. This information could contribute
to the treatments against infectious diseases, inflammation,
trauma, or neurodegeneration accompanying inflammation.
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